
### [NCIT:C9105](http://purl.obolibrary.org/obo/NCIT_C9105)
**Label:** Oropharyngeal Carcinoma

**Subclasses:** [NCIT:C6039](http://purl.obolibrary.org/obo/NCIT_C6039) (Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C8218](http://purl.obolibrary.org/obo/NCIT_C8218) (Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C8219](http://purl.obolibrary.org/obo/NCIT_C8219) (Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7), [NCIT:C8217](http://purl.obolibrary.org/obo/NCIT_C8217) (Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C4590](http://purl.obolibrary.org/obo/NCIT_C4590) (Stage 0 Oropharyngeal Carcinoma AJCC v6 and v7), [NCIT:C91248](http://purl.obolibrary.org/obo/NCIT_C91248) (Oropharyngeal Carcinoma by AJCC v7 Stage), [NCIT:C87055](http://purl.obolibrary.org/obo/NCIT_C87055) (Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma), [NCIT:C68610](http://purl.obolibrary.org/obo/NCIT_C68610) (Oropharyngeal Undifferentiated Carcinoma), [NCIT:C8181](http://purl.obolibrary.org/obo/NCIT_C8181) (Oropharyngeal Squamous Cell Carcinoma), [NCIT:C9218](http://purl.obolibrary.org/obo/NCIT_C9218) (Stage IV Oropharyngeal Carcinoma AJCC v6), [NCIT:C8049](http://purl.obolibrary.org/obo/NCIT_C8049) (Stage II Oropharyngeal Carcinoma AJCC v6 and v7), [NCIT:C115089](http://purl.obolibrary.org/obo/NCIT_C115089) (Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C8048](http://purl.obolibrary.org/obo/NCIT_C8048) (Stage I Oropharyngeal Carcinoma AJCC v6 and v7), [NCIT:C115088](http://purl.obolibrary.org/obo/NCIT_C115088) (Stage III Oropharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C115087](http://purl.obolibrary.org/obo/NCIT_C115087) (Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C8221](http://purl.obolibrary.org/obo/NCIT_C8221) (Recurrent Oropharyngeal Squamous Cell Carcinoma), [NCIT:C115086](http://purl.obolibrary.org/obo/NCIT_C115086) (Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C8220](http://purl.obolibrary.org/obo/NCIT_C8220) (Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7), [NCIT:C6241](http://purl.obolibrary.org/obo/NCIT_C6241) (Oropharyngeal Adenoid Cystic Carcinoma), [NCIT:C115093](http://purl.obolibrary.org/obo/NCIT_C115093) (Recurrent Oropharyngeal Undifferentiated Carcinoma), [NCIT:C8050](http://purl.obolibrary.org/obo/NCIT_C8050) (Stage III Oropharyngeal Carcinoma AJCC v6), [NCIT:C8051](http://purl.obolibrary.org/obo/NCIT_C8051) (Recurrent Oropharyngeal Carcinoma), [NCIT:C90523](http://purl.obolibrary.org/obo/NCIT_C90523) (Oropharyngeal Carcinoma by AJCC v6 Stage), [NCIT:C126751](http://purl.obolibrary.org/obo/NCIT_C126751) (Oropharyngeal Basaloid Carcinoma), [NCIT:C126750](http://purl.obolibrary.org/obo/NCIT_C126750) (Oropharyngeal Poorly Differentiated Carcinoma), [NCIT:C89023](http://purl.obolibrary.org/obo/NCIT_C89023) (Stage IV Oropharyngeal Carcinoma AJCC v7), [NCIT:C89021](http://purl.obolibrary.org/obo/NCIT_C89021) (Stage III Oropharyngeal Carcinoma AJCC v7), 

**Class expressions from DL-Learner:**

- [UBERON:0001952](http://purl.obolibrary.org/obo/UBERON_0001952) (epithelium of oropharynx) 66.67%
- [UBERON:0001729](http://purl.obolibrary.org/obo/UBERON_0001729) (oropharynx) 66.67%
- [NCIT:C17359](http://purl.obolibrary.org/obo/NCIT_C17359) (TP53 Gene) 66.67%
- [UBERON:0003351](http://purl.obolibrary.org/obo/UBERON_0003351) (pharyngeal epithelium) and [UBERON:0004808](http://purl.obolibrary.org/obo/UBERON_0004808) (gastrointestinal system epithelium) 66.67%
- [UBERON:0003351](http://purl.obolibrary.org/obo/UBERON_0003351) (pharyngeal epithelium) 52.02%
- Thing 51.76%
- [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) 43.05%
- [UBERON:0010000](http://purl.obolibrary.org/obo/UBERON_0010000) (multicellular anatomical structure) 36.81%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 36.71%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 36.69%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 36.34%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 36.31%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 36.00%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 36.00%
- [NCIT:C20917](http://purl.obolibrary.org/obo/NCIT_C20917) (Cell Cycle Gene) 32.48%


